📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Developing a predictive signature for two trial endpoints using the cross-validated risk scores method. (2023)

First Author: Cherlin S

Attributed to: Developing efficient perpetual platform trials to study multiple treatments and multiple biomarkers funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/biostatistics/kxaa055

PubMed Identifier: 34165151

Publication URI: http://europepmc.org/abstract/MED/34165151

Type: Journal Article/Review

Volume: 24

Parent Publication: Biostatistics (Oxford, England)

Issue: 2

ISSN: 1465-4644